ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2025
Strain-specific responses to dextran sulfate sodium-induced ulcerative colitis in BALB/c and C57BL/6 mice: Comparative analysis of local versus extra-intestinal manifestations.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dimethyl itaconate attenuates dextran sulfate sodium-induced ulcerative colitis in BALB/c mice: investigations on the TXNIP/NLRP3 inflammasome signaling pathway.Inflammopharmacology · 2026Article
- Xanthan gum intake modifies the colon microbiota profile and causes mild colon inflammation in rats.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
OBJECTIVE AND
designDextran sulfate sodium (DSS)-induced colitis in rodents is considered a well-established experimental model for the induction of ulcerative colitis (UC) and its extra-intestinal manifestations (EIMs). The influence of strain on EIMs of UC remains poorly understood. The present study elucidated the strain-specific responses to different concentrations of DSS and its effects on the local (colon), systemic (DNA damage in peripheral blood), and extra-intestinal (liver, pancreas, brain) manifestations.
methodsBALB/c and C57BL/6 mice, two commonly used rodent strains, were assigned to control and DSS (0.5%, 1%, 2%, and 3% w/v) treatment groups. DSS was provided in drinking water for 7 days over three cycles, with a 7-day inter-cycle remission. No other treatments or interventions were provided.
resultsBALB/c exhibited gradual weight loss even at the lower doses of DSS, while C57BL/6 showed an early and sustained weight loss, particularly at the higher doses, contributing to greater severity and mortality. C57BL/6 exhibited significant systemic and colonic damage, with elevated inflammatory markers (nitrite, TNF-α, IL-1β, LPS) and reduced IL-10 in all the target organs. In contrast, MPO activity and goblet cell loss were more significant in BALB/c. C57BL/6 exhibited significant increase in the intestinal permeability as well as expression of TLR4 in colon and brain as compared to BALB/c mice. Overall, C57BL/6 mice showed significant increase in UC associated brain damage at higher concentrations of DSS, whereas BALB/c exhibited significant liver and pancreatic damage in a dose-dependent manner to DSS exposure. The expression of apoptotic cells and NF-κB/ICAM-1 increased dose-dependently in both the strains, with distinct patterns of expressions at the target organs.
conclusionStrain-specific differences in inflammation, cell adhesion, apoptosis, and systemic DNA damage may be responsible for the differential severity, susceptibility, and the extent of colonic and extra-colonic damage observed in BALB/c and C57BL/6 mice. These findings underscore the importance of selecting an appropriate experimental model for UC and can offer translational relevance in predicting organ susceptibility and managing the intestinal and extraintestinal complications.
Indexed as
Identifiers
40742555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.